Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Endocrine Disruptors
EPA Endocrine Program Unlikely to Change Despite Retraction of Synergy Study
November 24th, 1997
The U.S. Environmental Protection Agency (EPA) has indicated that it will not change its research or policy regarding endocrine disruption, despite the recent retraction of an influential Tulane University study on synergy among estrogenic chemicals. EPA said that while the retraction invalidates the methods used by the Tulane (New Orleans, Louisiana) researchers, it does not negate the substantial body of scientific literature on endocrine disruption and synergism. Tulane researchers formally retracted their findings due to repeated failures to replicate their original results. The study, "Synergistic Activation of Estrogen Receptor with...
Source: Cancer Weekly (1997-11-24)
|
